A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara...
Date First Received: December 21, 2007
Last Updated: July 23, 2008
Verified by: The University of Texas Health Science Center, Houston, July 2008
Clinical Trial Phase: Phase 4 | Start Date: December 2007
Overall Status: Recruiting
Estimated Enrollment: 40
Brief Summary
Official Title: “Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp”
Condition Keyword(s):
Intervention(s):
A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.
Study Type: Interventional
Study Design: Treatment, Open Label, Historical Control, Single Group Assignment, Efficacy Study
Study Primary Completion Date: December 2008
Intervention(s) in this Clinical Trial
- Biological: Imiquimod and Interferon alpha
- Imiquimod first two weeks and last two weeks. Interferon middle five weeks.
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: Treated
Outcome Measures for this Clinical Trial
Primary Measures
- resolution of basal cell carcinoma
- Time Frame: 2 years
Safety Issue?: No
- Time Frame: 2 years
Secondary Measures
- resolution of basal cell carcinoma
- Time Frame: 2 years
Safety Issue?: No
- Time Frame: 2 years
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Nodular or superficial basal cell carcinoma on the skin excluding scalp or face
Exclusion Criteria:
- Pregnancy
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: The University of Texas Health Science Center, Houston
Overall Clinical Trial Officials and Contacts
Stephen B Tucker, M.D. Principal Investigator University of Texas Health Science Center of Houston Dermatology Clinic
Overall Contact: Stephen B Tucker, M.D. 281-773-6774 stephen.b.tucker@uth.tmc.edu
Additional Information
Information obtained from ClinicalTrials.gov on October 10, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00581425
Study ID Number: HSC-MS-06-0478
ClinicalTrials.gov Identifier: NCT00581425
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.